RA Ross

411 total citations
6 papers, 323 citations indexed

About

RA Ross is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, RA Ross has authored 6 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Cellular and Molecular Neuroscience and 2 papers in Cognitive Neuroscience. Recurrent topics in RA Ross's work include Cannabis and Cannabinoid Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Sleep and Wakefulness Research (2 papers). RA Ross is often cited by papers focused on Cannabis and Cannabinoid Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Sleep and Wakefulness Research (2 papers). RA Ross collaborates with scholars based in United Kingdom, Canada and United States. RA Ross's co-authors include Roger G. Pertwee, L. A. Stevenson, M. G. Cascio, Christopher M. Henstridge, Ken Mackie, J.C. McGrath, Jennifer Whyte, Daniele Bolognini, CJ Fowler and James J. Burston and has published in prestigious journals such as British Journal of Pharmacology, Clinical Pharmacology & Therapeutics and Clinical Neurophysiology.

In The Last Decade

RA Ross

6 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RA Ross United Kingdom	5	251	114	79	76	48	6	323
Camille Soubrane United Kingdom	4	266 1.1×	188 1.6×	65 0.8×	49 0.6×	30 0.6×	5	406
Carmen del Río Spain	9	303 1.2×	105 0.9×	111 1.4×	88 1.2×	29 0.6×	16	451
Christopher Krewenka Austria	13	173 0.7×	116 1.0×	77 1.0×	66 0.9×	22 0.5×	19	357
Masanori Nozako Japan	8	179 0.7×	85 0.7×	60 0.8×	31 0.4×	41 0.9×	10	378
R. Mechoulam Israel	5	363 1.4×	199 1.7×	80 1.0×	63 0.8×	27 0.6×	7	487
Barbara Kranner Austria	10	165 0.7×	138 1.2×	84 1.1×	71 0.9×	19 0.4×	15	384
Chanté Muller United States	4	356 1.4×	145 1.3×	61 0.8×	58 0.8×	39 0.8×	5	476
Georgia Watt Australia	6	231 0.9×	90 0.8×	36 0.5×	88 1.2×	26 0.5×	11	306
Alejandro Lillo Spain	11	204 0.8×	165 1.4×	147 1.9×	47 0.6×	23 0.5×	27	458
Lia Vorobiev Israel	8	195 0.8×	98 0.9×	58 0.7×	33 0.4×	40 0.8×	11	417

Countries citing papers authored by RA Ross

Since Specialization

Citations

This map shows the geographic impact of RA Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Ross more than expected).

Fields of papers citing papers by RA Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RA Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Ross. The network helps show where RA Ross may publish in the future.

Co-authorship network of co-authors of RA Ross

This figure shows the co-authorship network connecting the top 25 collaborators of RA Ross. A scholar is included among the top collaborators of RA Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RA Ross. RA Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mielnik, Catharine A., et al.. (2019). The behavioral effects of CBD and THC in mouse models of psychosis. Clinical Neurophysiology. 130(8). e119–e119. 1 indexed citations

2.

Bolognini, Daniele & RA Ross. (2015). Medical cannabis vs. synthetic cannabinoids: What does the future hold?. Clinical Pharmacology & Therapeutics. 97(6). 568–570. 10 indexed citations

3.

Ross, RA, et al.. (2010). Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and ‘cannabinoid‐like’ receptors in small arteries. British Journal of Pharmacology. 159(4). 787–796. 71 indexed citations

4.

Thors, Lina, James J. Burston, Benedict J. Alter, et al.. (2010). Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. British Journal of Pharmacology. 160(3). 549–560. 39 indexed citations

5.

Cascio, M. G., et al.. (2009). Evidence that the plant cannabinoid cannabigerol is a highly potent α₂‐adrenoceptor agonist and moderately potent 5HT_1Areceptor antagonist. British Journal of Pharmacology. 159(1). 129–141. 178 indexed citations

6.

Mackie, Ken & RA Ross. (2008). CB₂ cannabinoid receptors: new vistas. British Journal of Pharmacology. 153(2). 177–178. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact